NPPA has Put A Cap on Trade Margin of 42 Select Non-scheduled Anti-Cancer Medicines Under ‘Trade Margin Rationalization (TMR)
NPPA monitors the ceiling price of the scheduled formulations to ensure that the MRP of such formulations are within the range of ceiling price and monitors non-scheduled formulations to ensure that their MRP does not increase by more than 10% during the preceding twelve months.